This report summarises national passive surveillance data collated in the Adverse Drug Reactions Advisory Committee (ADRAC) database at 30 September 2006 for adverse events following immunisation (AEFI) reported for children aged less than 7 years who received vaccines between 1 January and 30 June 2006.1–3 It is the fi rst full reporting period for AEFI data following the introduction of a new...

This, the 2nd annual immunisation coverage report, documents trends during 2008 for a range of standard measures derived from Australian Childhood Immunisation Register data, including overall coverage at standard age milestones and for individual vaccines included on the National Immunisation Program (NIP). Coverage by indigenous status and mapping by smaller geographic areas as well as trends...

Nepal initiated Expanded Programme on Immunisation (EPI) in the fiscal year 1978/79. By the next decade the programme was expanded to all the 75 districts of the country. However, due to various structural changes, the programme lagged behind and the national coverage of immunisation to around 80% could be reached by the year 2000 only. By 2004, some Vaccine Preventable Diseases (VPD), namely n...

The diphtheria epidemic in eastern Europe and the worldwide increase in diphtheria morbidity have sparked discussion on whether people in western Europe are adequately protected. 2 In western Europe, the effectiveness of long term protection afforded by immunisation programmes is under debate. In Belgium, the national immunisation programme against diphtheria was introduced in 1959. Vaccination...

BACKGROUND The English health system experienced a large-scale reorganisation in April 2013. A national tri-partite delivery framework involving the Department of Health, NHS England and Public Health England was agreed and a new local operational model applied. Evidence about how health system re-organisations affect constituent public health programmes is sparse and focused on low and middle ...

Hepatitis B is hyperendemic in Taiwan; more than 15% of adults are chronic carriers of the virus and longterm sequelae (chronic active hepatitis, cirrhosis, and hepatocellular carcinoma) are common. A national immunisation programme was implemented in 1984 to tackle the problem. This entailed immunisation of newborn children, followed by susceptible school children and young adults. The program...

The Norwegian immunisation register, SYSVAK, is a national electronic immunisation register. It became nationwide in 1995. The major aim was to register all vaccinations in the Childhood Immunisation Programme to ensure that all children are offered adequate vaccination according to schedule in the programme, and to secure high vaccination coverage. Notification to SYSVAK is mandatory, based on...

Invasive meningococcal disease (IMD) is a severe bacterial infectious disease with high mortality and morbidity rates worldwide. In recent years, industrialised countries have implemented vaccines targeting IMD in their National Immunisation Programmes (NIPs). In 2002, the Netherlands successfully implemented a single dose of meningococcal serogroup C conjugate vaccine at the age of 14 months a...

Vaccination considered as one of the most cost-effective health interventions worldwide  through prevention and control of many serious childhood diseases (1). It is estimated  global coverage of  Dose 3 of Diphtheria, Tetanus, and Pertussis (DTP3)among children one year old has been 86% in 2014 (by range from 77% to 96%  in African Region and Western Pacific Region; respectively) (2). Globally...